Brief: Palisade Bio Strengthens Clinical Leadership Team With Appointment Of James Izanec
02/12/2025 13:46
Dec 2 (Reuters) - Palisade Bio Inc PALI.O: PALISADE BIO STRENGTHENS CLINICAL LEADERSHIP TEAM WITH APPOINTMENT OF JAMES IZANEC, MD, AGAF AS VICE PRESIDENT, CLINICAL DEVELOPMENT Source text: ID:nGNX8C5FpB Further company coverage: PALI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Palisade Bio
See all newsPalisade Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Palisade Bio Q2 net loss widens on higher R&D costs
Brief: Palisade Bio Q2 EPS USD -0.05
Palisade Bio Inc expected to post a loss of 5 cents a share - Earnings Preview
Brief: Palisade Bio Inc - May Offer And Sell Up To $300 Million Of Securities - SEC Filing